Australia's leading drug reference system
In Australia, UBM Medica publishes the MIMS range of drug and medical references. For over 40 years, MIMS Australia has been providing Australian medical practitioners and other healthcare professionals with the independent, timely and easily accessible drug information they need to make safe prescribing and dispensing decisions.
The MIMS range of publications covers a wide array of subjects and specialties. From drug prescribing information to disease diagnosis, hospital equipment to veterinary products, and drugs in sport to dental abstracts, there is a UBM Medica publication that is helping keep Australia's healthcare professionals informed and up-to-date.
MIMS publications reach over 25,000 healthcare professionals in Australia alone, and are the preferred drug reference system for the majority of Australian general practitioners and pharmacists. In fact, 98% of general practitioners use MIMS Bi-Monthly an average of 20 times per week at the point of prescription, to access such information as side effects, contraindications, product indications and PBS listings.
Independently evaluated
The monographs presented in MIMS publications represent Therapeutic Goods Administration (TGA) approved product information, which is the result of years of research and development by the sponsor company, and of painstaking evaluation and review by the Drug Safety and Evaluation Branch of the TGA.
The production of this information by UBM Medica is overseen by an independent Editorial Board to ensure accuracy of information, as well as standardisation of headings, format and terminology to enhance the usability of the data.
This vital information is distributed to key decision makers by a variety of media which leverage the power of both traditional printed format and emerging technologies.
Embracing new communication technologies
The advent of new electronic technologies has paved the way for enhanced information delivery.
Electronic publishing is allowing us to provide professionals with an easy and convenient way to access the exact information they need, when they need it. It is these electronic advances that are the focus of our future developments.
UBM Medica is responding on a worldwide basis to the challenge of new technologies by developing enhanced databases for use on CD-ROM, as well as by expanding information resources via online applications such as the Internet and closed user networks.
These changes reflect the growing demand for accurate, reliable and independent information about an ever expanding range of new and increasingly complex pharmaceutical products.
Independent, up-to-date information
Wherever drug information is published by UBM Medica, the aim is always the same - to offer independent, up-to-date information to health professionals and consumers. Great emphasis is always placed upon data preparation and research, as well as the development of new information technologies.
In the future, UBM Medica will be actively responding to new global communication technologies by developing enhanced databases and expanded Internet and online resources to better serve the world's expanding healthcare information needs. |
